BeStock  
Stocks › TGTX

TG Therapeutics TGTX

US equityMarket cap rank #1443
$63.34 −$1.54 (-2.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $63.21 -0.21%
Open$64.10
Prev close$64.88
Day range$63.12 – $65.64
Volume2.09M
Market cap$9.57B
P/E (TTM)94.5
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

TGTX at a glance

TG Therapeutics stock (TGTX) sits at $63.34, down 2.37% today. The business is worth $9.57B in the market, good for #1443 of 3753 on our coverage list.

Over the past 52 weeks it has traded between $26.76 and $68.03, so it sits 6.9% below the top of that range. Holders are ahead 98.2% over twelve months, and up 13.1% across the last three months.

On the chart it holds above both the 50-day ($57.58) and 200-day ($46.25) moving averages; RSI is 57, and the last 30 sessions moved at roughly 44% annualized volatility.

Revenue for the quarter ended Sep 2026 was $259.94M, up 60.7% from a year earlier, with $55.46M of net profit (a 11.8% margin).

Buyers are paying 94.5 times trailing earnings, 1,176% above its five-year average of 7.4.

6 analysts follow the stock and the average call is "buy". The mean target, $76.40, sits 20.6% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$63.20 / $64.57
Average price today$64.03
Volume2.09MAvg (90d) 1.99M
Turnover$133.78M
Turnover rate1.45%of shares outstanding
Volume ratio1.29vs. recent average pace
Day amplitude3.89%
Market cap$9.57B
Float market cap$9.16B
Shares outstanding144.54M
EPS (TTM)$2.77
P/E (TTM)94.54
P/B16.73
Book value / share$3.79
Earnings yield1.06%
Net profit (TTM)$418.68M
Net assets$572.09M
30-day volatility43.8%annualized
Avg daily range (ATR)5.52%of price, 14 days
Max drawdown (1y)-21.8%-4.2% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

A
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

6 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 84.4 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation4.1
Growth—
Profitability99.0
Momentum99.4
Financial health73.9
Analyst view49.8

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$76.40+20.6% vs. current price
Consensus ratingBuy6 analysts covering
Morningstar fair value$61.92Close to fair value

Wall Street’s average 12-month target is $76.40, 20.6% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $61.92, so shares trade 2.3% above that estimate. On earnings multiple, it sits in the 88th percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-2.4%
1 week
-1.8%
1 month
+19.1%
3 months
+13.1%
6 months
+63.0%
Year to date
+112.5%
1 year
+98.2%
Day range
$63.12$65.64
52-week range
$26.76$68.03

Technical signals

Full technicals →
Trend readStrong uptrend

7 bullish · 0 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average+3.0%Bullish
Price vs 50-day average+10.0%Bullish
Price vs 200-day average+36.9%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)57.2Bullish
MACD (12,26,9)2.27Bullish
Bollinger band position64%Bullish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How TGTX ranks on BeStock

Market value#1440 of 3734
P/E (cheapest = 1)#2799 of 2917
Closeness to 52-week high#336 of 3724
Dollar volume today#849 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

TGTX is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on TGTX.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on TGTX

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

TGTX stock: common questions

How is TG Therapeutics stock doing today?

$63.34 is the latest print for TGTX, a move of -2.37% against yesterday's close of $64.88. Today's low and high so far: $63.12 and $65.64.

How big is TG Therapeutics?

Equity value comes to $9.57B at the current price. By that measure it is number 1443 of the 3753 names in our coverage.

Is TGTX expensive on earnings?

Buyers pay 94.5 times the last twelve months of profit (EPS $2.77). Averaged over five years the multiple has been 7.4, and today's level ranks in the 88th percentile of its own history.

What's the 52-week trading range for TG Therapeutics?

The year's floor is $26.76 and the ceiling $68.03. Shares are 6.9% away from that ceiling.

What's the dividend situation for TGTX?

Our data shows no dividend paid by TG Therapeutics over the trailing twelve months.

What are analysts saying about TGTX?

Of 6 analysts, 83% say buy, 0% hold and 17% sell. Price targets average $76.40, with the most cautious at $71.00 and the most optimistic at $86.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on TGTX.

Sign in to join the discussion.

Scroll to Top